BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9710796)

  • 1. Phospholamban modulates murine atrial contractile parameters and responses to beta-adrenergic agonists.
    Kadambi VJ; Koss KL; Grupp IL; Kranias EG
    J Mol Cell Cardiol; 1998 Jul; 30(7):1275-84. PubMed ID: 9710796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions.
    Brittsan AG; Kiss E; Edes I; Grupp IL; Grupp G; Kranias EG
    J Mol Cell Cardiol; 1999 Sep; 31(9):1725-37. PubMed ID: 10471356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.
    Neumann J; Boknik P; DePaoli-Roach AA; Field LJ; Rockman HA; Kobayashi YM; Kelley JS; Jones LR
    J Mol Cell Cardiol; 1998 Oct; 30(10):1991-2002. PubMed ID: 9799653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of phospholamban is not associated with lower beta-adrenergic activation in rat atria.
    Kaasik A; Paju K; Minajeva A; Ohisalo J
    Mol Cell Biochem; 2001 Jul; 223(1-2):109-15. PubMed ID: 11681711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CaMKII-mediated increased lusitropic responses to beta-adrenoreceptor stimulation in ANP-receptor deficient mice.
    Yurukova S; Kilić A; Völker K; Leineweber K; Dybkova N; Maier LS; Brodde OE; Kuhn M
    Cardiovasc Res; 2007 Mar; 73(4):678-88. PubMed ID: 17107670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of inhibitory G-proteins mediates a reduction in atrial beta-adrenergic signaling by enhancing eNOS expression.
    Danson EJ; Zhang YH; Sears CE; Edwards AR; Casadei B; Paterson DJ
    Cardiovasc Res; 2005 Sep; 67(4):613-23. PubMed ID: 15936740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to beta-adrenergic stimulation in cirrhotic rats.
    Ebrahimi F; Tavakoli S; Hajrasouliha AR; Sadeghipour H; Dehghani M; Ahmadi SH; Dehpour AR
    Fundam Clin Pharmacol; 2006 Oct; 20(5):461-71. PubMed ID: 16968416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced myocardial relaxation in vivo in transgenic mice overexpressing the beta2-adrenergic receptor is associated with reduced phospholamban protein.
    Rockman HA; Hamilton RA; Jones LR; Milano CA; Mao L; Lefkowitz RJ
    J Clin Invest; 1996 Apr; 97(7):1618-23. PubMed ID: 8601626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enhanced contractility of the phospholamban-deficient mouse heart persists with aging.
    Slack JP; Grupp IL; Dash R; Holder D; Schmidt A; Gerst MJ; Tamura T; Tilgmann C; James PF; Johnson R; Gerdes AM; Kranias EG
    J Mol Cell Cardiol; 2001 May; 33(5):1031-40. PubMed ID: 11343424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility.
    Koss KL; Grupp IL; Kranias EG
    Basic Res Cardiol; 1997; 92 Suppl 1():17-24. PubMed ID: 9202840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered calcium handling is critically involved in the cardiotoxic effects of chronic beta-adrenergic stimulation.
    Engelhardt S; Hein L; Dyachenkow V; Kranias EG; Isenberg G; Lohse MJ
    Circulation; 2004 Mar; 109(9):1154-60. PubMed ID: 14967726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy.
    El-Armouche A; Wittköpper K; Degenhardt F; Weinberger F; Didié M; Melnychenko I; Grimm M; Peeck M; Zimmermann WH; Unsöld B; Hasenfuss G; Dobrev D; Eschenhagen T
    Cardiovasc Res; 2008 Dec; 80(3):396-406. PubMed ID: 18689792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic triadin 1 overexpression alters SR Ca2+ handling and leads to a blunted contractile response to beta-adrenergic agonists.
    Kirchhefer U; Jones LR; Begrow F; Boknik P; Hein L; Lohse MJ; Riemann B; Schmitz W; Stypmann J; Neumann J
    Cardiovasc Res; 2004 Apr; 62(1):122-34. PubMed ID: 15023559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenylyl cyclase type V deletion increases basal left ventricular function and reduces left ventricular contractile responsiveness to beta-adrenergic stimulation.
    Tang T; Lai NC; Roth DM; Drumm J; Guo T; Lee KW; Han PL; Dalton N; Gao MH
    Basic Res Cardiol; 2006 Mar; 101(2):117-26. PubMed ID: 16283593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase of cardiac contractility.
    Zhao W; Uehara Y; Chu G; Song Q; Qian J; Young K; Kranias EG
    J Mol Cell Cardiol; 2004 Aug; 37(2):607-12. PubMed ID: 15276030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential phospholamban gene expression in murine cardiac compartments. Molecular and physiological analyses.
    Koss KL; Ponniah S; Jones WK; Grupp IL; Kranias EG
    Circ Res; 1995 Aug; 77(2):342-53. PubMed ID: 7542181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation.
    Gramolini AO; Trivieri MG; Oudit GY; Kislinger T; Li W; Patel MM; Emili A; Kranias EG; Backx PH; Maclennan DH
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2446-51. PubMed ID: 16461894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.
    Luo W; Grupp IL; Harrer J; Ponniah S; Grupp G; Duffy JJ; Doetschman T; Kranias EG
    Circ Res; 1994 Sep; 75(3):401-9. PubMed ID: 8062415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholamban ablation and compensatory responses in the mammalian heart.
    Chu G; Ferguson DG; Edes I; Kiss E; Sato Y; Kranias EG
    Ann N Y Acad Sci; 1998 Sep; 853():49-62. PubMed ID: 10603936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation.
    Greiser M; Neuberger HR; Harks E; El-Armouche A; Boknik P; de Haan S; Verheyen F; Verheule S; Schmitz W; Ravens U; Nattel S; Allessie MA; Dobrev D; Schotten U
    J Mol Cell Cardiol; 2009 Mar; 46(3):385-94. PubMed ID: 19100271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.